Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | EDNRA | P25101 | 7/20 | 0.37 |
| ▸ | EDNRB | P24530 | 3/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.32 |
| ▸ | CDK8 | P49336 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10331688 | 1.00 | L3MBTL1 (0.45) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL10331703 | 1.00 | L3MBTL1 (0.45) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL10309959 | 0.98 | L3MBTL1 (0.43) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL15470144 | 0.96 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL20114090 | 0.96 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL20114040 | 0.96 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL20114134 | 0.96 | KDM4E (0.42) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL10331571 | 0.96 | KDM4E (0.38) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL10331572 | 0.96 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL20114117 | 0.95 | L3MBTL1 (0.40) | L3MBTL1KDM4EATMEDNRAEDNRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220144856-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2022-05-12 | — | — | US | disclosed |
| US-20210328150-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2021-10-21 | — | — | US | disclosed |
| US-20210280796-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2021-09-09 | — | — | US | disclosed |
| WO-2018080067-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING SAME | 주식회사 두산 | 2018-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210280796-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE | OR10J3, ELAVL1, VDAC2 | L3MBTL1 82/4885KDM4E 1212/4885ATM 2041/4885 |
| US-20220144856-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | OR10J3, L1CAM, EPCAM | L3MBTL1 110/4885KDM4E 2347/4885ATM 1746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.